Dengue virus.
Dengue is the most prevalent arthropod-borne virus affecting humans today. The virus group consists of 4 serotypes that manifest with similar symptoms. Dengue causes a spectrum of disease, ranging from a mild febrile illness to a life-threatening dengue hemorrhagic fever. Breeding sites for the mosquitoes that transmit dengue virus have proliferated, partly because of population growth and uncontrolled urbanization in tropical and subtropical countries. Successful vector control programs have also been eliminated, often because of lack of governmental funding. Dengue viruses have evolved rapidly as they have spread worldwide, and genotypes associated with increased virulence have spread across Asia and the Americas. This article describes the virology, epidemiology, clinical manifestations and outcomes, and treatments/vaccines associated with dengue infection.
Department of Microbiology and Molecular Genetics, Center for Vaccine Research, University of Pittsburgh, PA 15261, USA. tmr15@pitt.edu <tmr15@pitt.edu>
Ted M
TM
Ross
D000330:Aedes / Q000821:virology; D000818:Animals; D003715:Dengue / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D053059:Dengue Vaccines / Q000276:immunology; D003716:Dengue Virus / Q000276:immunology / Q000302:isolation & purification*; D003937:Diagnosis, Differential; D006801:Humans; D007303:Insect Vectors / Q000821:virology
D053059:Dengue Vaccines